These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16462891)

  • 1. The influence of cholesterol and lipid metabolism on host cell structure and hepatitis C virus replication.
    Sagan SM; Rouleau Y; Leggiadro C; Supekova L; Schultz PG; Su AI; Pezacki JP
    Biochem Cell Biol; 2006 Feb; 84(1):67-79. PubMed ID: 16462891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor alpha antagonism inhibits hepatitis C virus replication.
    Rakic B; Sagan SM; Noestheden M; Bélanger S; Nan X; Evans CL; Xie XS; Pezacki JP
    Chem Biol; 2006 Jan; 13(1):23-30. PubMed ID: 16426968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct imaging of the disruption of hepatitis C virus replication complexes by inhibitors of lipid metabolism.
    Lyn RK; Kennedy DC; Sagan SM; Blais DR; Rouleau Y; Pegoraro AF; Xie XS; Stolow A; Pezacki JP
    Virology; 2009 Nov; 394(1):130-42. PubMed ID: 19747705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts.
    Aizaki H; Lee KJ; Sung VM; Ishiko H; Lai MM
    Virology; 2004 Jul; 324(2):450-61. PubMed ID: 15207630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting lipid metabolism in the treatment of hepatitis C virus infection.
    Amemiya F; Maekawa S; Itakura Y; Kanayama A; Matsui A; Takano S; Yamaguchi T; Itakura J; Kitamura T; Inoue T; Sakamoto M; Yamauchi K; Okada S; Yamashita A; Sakamoto N; Itoh M; Enomoto N
    J Infect Dis; 2008 Feb; 197(3):361-70. PubMed ID: 18248300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-Amino-2(5H)furanones as inhibitors of subgenomic hepatitis C virus RNA replication.
    Iannazzo D; Piperno A; Romeo G; Romeo R; Chiacchio U; Rescifina A; Balestrieri E; Macchi B; Mastino A; Cortese R
    Bioorg Med Chem; 2008 Nov; 16(21):9610-5. PubMed ID: 18835180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New efficient replication system with hepatitis C virus genome derived from a patient with acute hepatitis C.
    Mori K; Abe K; Dansako H; Ariumi Y; Ikeda M; Kato N
    Biochem Biophys Res Commun; 2008 Jun; 371(1):104-9. PubMed ID: 18406345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and molecular biology of HCV infection and hepatitis.
    Tang H; Grisé H
    Clin Sci (Lond); 2009 Jun; 117(2):49-65. PubMed ID: 19515018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic comparison of human hepatoma Huh-7 cell clones with different hepatitis C virus replication efficiencies.
    Inoue Y; Murakami K; Hmwe SS; Aizaki H; Suzuki T
    Jpn J Infect Dis; 2007 Jul; 60(4):173-8. PubMed ID: 17642525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteome analysis of human liver carcinoma Huh7 cells harboring hepatitis C virus subgenomic replicon.
    Fang C; Yi Z; Liu F; Lan S; Wang J; Lu H; Yang P; Yuan Z
    Proteomics; 2006 Jan; 6(2):519-27. PubMed ID: 16317778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subproteomic study of hepatitis C virus replicon reveals Ras-GTPase-activating protein binding protein 1 as potential HCV RC component.
    Yi Z; Fang C; Pan T; Wang J; Yang P; Yuan Z
    Biochem Biophys Res Commun; 2006 Nov; 350(1):174-8. PubMed ID: 16996479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell culture-adaptive NS3 mutations required for the robust replication of genome-length hepatitis C virus RNA.
    Abe K; Ikeda M; Dansako H; Naka K; Kato N
    Virus Res; 2007 Apr; 125(1):88-97. PubMed ID: 17239465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructural and biochemical analyses of hepatitis C virus-associated host cell membranes.
    Ferraris P; Blanchard E; Roingeard P
    J Gen Virol; 2010 Sep; 91(Pt 9):2230-7. PubMed ID: 20484561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro replication models for the hepatitis C virus.
    Sheehy P; Mullan B; Moreau I; Kenny-Walsh E; Shanahan F; Scallan M; Fanning LJ
    J Viral Hepat; 2007 Jan; 14(1):2-10. PubMed ID: 17212638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of hepatitis C virus replicon by TGF-beta.
    Murata T; Ohshima T; Yamaji M; Hosaka M; Miyanari Y; Hijikata M; Shimotohno K
    Virology; 2005 Jan; 331(2):407-17. PubMed ID: 15629783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum-free cell culture system supplemented with lipid-rich albumin for hepatitis C virus (strain O of genotype 1b) replication.
    Abe K; Ikeda M; Ariumi Y; Dansako H; Kato N
    Virus Res; 2007 May; 125(2):162-8. PubMed ID: 17267063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of steroids on hepatitis C virus replication in vivo and in vitro.
    Henry SD; Metselaar HJ; Van Dijck J; Tilanus HW; Van Der Laan LJ
    Ann N Y Acad Sci; 2007 Sep; 1110():439-47. PubMed ID: 17911459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-alpha and ribavirin resistance of Huh7 cells transfected with HCV subgenomic replicon.
    Aus dem Siepen M; Oniangue-Ndza C; Wiese M; Ross S; Roggendorf M; Viazov S
    Virus Res; 2007 Apr; 125(1):109-13. PubMed ID: 17254660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host factors involved in the replication of hepatitis C virus.
    Moriishi K; Matsuura Y
    Rev Med Virol; 2007; 17(5):343-54. PubMed ID: 17563922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids.
    Kapadia SB; Chisari FV
    Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2561-6. PubMed ID: 15699349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.